FDA Mandate On Rx Firms Would Protect Reimportation Under Senate Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
The legislation requires drug manufacturers to notify FDA of any manufacturing changes that might circumvent reimportation. Bill sponsors include Dorgan, Kennedy and McCain.